Who we are


UCLA has been a leader in TMS treatment since the founding of our program 10 years ago. Our team of faculty experts, led by Andrew Leuchter, M.D., are board-certified psychiatrists with specialized training in TMS as well as mood, anxiety, and other disorders occurring from childhood through late life. As part of the Semel Institute, we are pioneers in research on TMS and other forms of neuromodulation, ensuring that patients receive the latest and most advanced treatment available.

You can read about all the psychiatrist members of our team below.

Andrew Leuchter, M.D.

Andrew F. Leuchter, MD, is Professor and Executive Vice Chair of the Department of Psychiatry and Biobehavioral Science, Director of the TMS Clinical and Research Program and the Neuromodulation Division, and Associate Director of the Semel Institute for Neuroscience and Human Behavior at UCLA. A graduate of Stanford University, Dr. Leuchter earned his medical degree from Baylor College of Medicine in Houston, Texas. He joined the UCLA faculty in 1986.

An internationally recognized expert on the treatment of mood disorders, Dr. Leuchter’s research focuses on the enhancement of treatment outcomes in depression. He is leading clinical trials to improve TMS treatment outcomes and develop novel technologies for treatment of depression and Post-Traumatic Stress Disorder (PTSD), including synchronized Transcranial Magnetic Stimulation (sTMS) and Trigeminal Nerve Stimulation (TNS). He uses brain-imaging techniques, such as quantitative electroencephalography (qEEG) and magnetic resonance imaging (MRI) to examine brain function and predict which treatments are most likely to benefit individual patients.

Dr. Leuchter is a Diplomat of the American Board of Psychiatry and Neurology as well as the American Board of Electroencephalography and Neurophysiology. He is a member of several professional organizations, including the American Psychiatric Association, the Clinical TMS Society, and the American Medical EEG Association. He has authored over 150 scientific articles on topics including neuromodulation for the treatment of depression, biomarkers to guide treatment of neuropsychiatric illness, and theories of antidepressant action. He also maintains an active clinical practice, specializing in consultation for and care of patients suffering from treatment-resistant depression.

For more information on Dr. Leuchter, please visit: www.andrewleuchter.com

David Krantz, M.D., Ph.D.

David Krantz is a Professor in Residence in the Department of Psychiatry and Biobehavioral Sciences at the David Geffen School of Medicine at UCLA.

An undergraduate at Brown University, he completed an MD/PhD in the Medical Scientist Training Program at UCLA in 1991, where he performed his dissertation on Drosophila eye development with Larry Zipursky. After a residency in psychiatry at UCLA, he was awarded a Howard Hughes Postdoctoral Fellowship for Physicians to investigate the regulation of vesicular neurotransmitter transporters in Robert Edwards' laboratory at UCSF.

He returned to UCLA in 2000, and is currently using Drosophila to study how changes in the function of neurotransmitter transporters may influence synaptic transmission and behavior.

UCLA Committees:

  • Neuroscience IDP Dissertation Committee (2002-ongoing; Chair, 2005-ongoing)
  • Neuroscience IDP Vice Chair (2007-2010)
  • Psychiatry Residency Research Track Oversight Committee (2003-ongoing; Chair, 2006-ongoing)
  • Medical Scientist Training Program Admissions Committee (2002-2007)
  • Neuroscience Seminar Speaker Selection Committee (2003-2013)

Jennifer G. Levitt, M.D.

Medical Board Certifications:

Psychiatry, American Board of Psychiatry and Neurology, 1993

Child & Adolescent Psychiatry, American Board of Psychiatry and Neurology, 1994

Fellowship:

Psychiatry, Stanford University School of Medicine, 1990-1991

Residency:

Psychiatry, Stanford University School of Medicine, 1987-1990

Child Psychiatry, UCLA Neuropsychiatric Hospital, 1991-1993

Internship:

Internal Medicine, University of North Carolina Hospitals, 1986-1987

Degree:

University of North Carolina, Chapel Hill, School of Medicine, MD, 1986

Jonathan Lee, M.D.

Jonathan Lee is a child and adolescent psychiatrist and fellow of the Royal College of Physicians and Surgeons of Canada. He completed his master’s thesis with Dr. Jeff Daskalakis at the Temerty Centre for Therapeutic Brain Intervention where he studied the clinical and neurophysiological effects of theta-burst stimulation in depressed youth. His research aims to expand treatment options for youth with neuropsychiatric conditions.

Medical Board Certifications:

Psychiatry, Royal College of Physicians and Surgeons of Canada, 2015

Child and Adolescent Psychiatry, Royal College of Physicians and Surgeons of Canada, 2016

Fellowship:

Brain Stimulation/Child and Adolescent Psychiatry, Centre for Addiction and Mental Health, Temerty Centre for Therapeutic Brain Intervention

Residency:

Psychiatry, University of Toronto, 2010-2015

Child and Adolescent Psychiatry, University of Toronto, 2015-2016

Internship:

Queen’s University, 2008-2010

Degree:

Queen’s University, School of Medicine, MD, 2010

Institute of Medical Science, MS, 2018

Nathaniel Ginder, M.D., Ph.D.

Nathaniel Ginder, MD, PhD, is fellowship trained in Child and Adolescent Psychiatry. He has interests in applications of TMS for children and adolescents as well as its application in addictive behaviors.

Medical Board Certifications:

Psychiatry, American Board of Psychiatry and Neurology, 2015

Child & Adolescent Psychiatry, American Board of Psychiatry and Neurology, 2017

Fellowship:

Child and Adolescent Psychiatry, UCLA Semel Institute for Neuroscience and Human Behavior, 2015-2018

Residency:

Psychiatry, UCLA Semel Institute for Neuroscience and Human Behavior, 2013-2015

Internship:

Psychiatry, UCLA Semel Institute for Neuroscience and Human Behavior, 2012-2013

Degrees:

Washington University in St. Louis, School of Medicine, MD, 2012

Iowa State University, PhD, Biochemistry, 2008

Reza Tadayon-Nejad, M.D., Ph.D.

Dr. Tadayon-Nejad is an Assistant Clinical Professor of Psychiatry at UCLA and Visiting Associate faculty in Neuroscience at California Institute of Technology.

His clinical focus is on treatment of refractory depression, OCD and comorbid OCD-Depression by using multimodal treatment options of Transcranial Magnetic Stimulation (TMS), advanced pharmacology and Exposure and Response Prevention therapy.

In collaboration with decision neuroscientists at Caltech, Dr. Tadayon-Nejad research explores the neurobehavioral and circuit mechanisms of abnormal decision-making in psychiatric disorders, particularly OCD, by using methods and concepts from computational neuroscience, neuroimaging (fMRI, DTI, EEG) and noninvasive neurostimulation (tDCS, TMS). His research is funded by NIMH and Brain & Behavior Research Foundation (NARSAD).

Medical Board Certifications:

Psychiatry, American Board of Psychiatry and Neurology, 2015

Fellowship:

NIMH funded T32 fellowship in neuroscience of mental health with focus on psychiatric neuroimaging (fMRI, DTI, EEG), University of Illinois at Chicago, 2014-2016

Residency:

Psychiatry, University of Illinois at Chicago, 2011-2015

Degrees:

University of Calgary, PhD, 2011

Ahwaz University of Medical Sciences, MD, 2004

Scott A. Wilke, M.D., Ph.D.

Dr. Wilke is an Assistant Clinical Professor in the Department of Psychiatry and Biobehavioral Sciences at UCLA and is a psychiatrist and neuroscientist. His research investigates the structure and function of neural circuits that underlie neuropsychiatric disorders. Dr. Wilke received his BS in neurobiology from the University of Washington and went on to earn his MD and PhD in neuroscience in the Medical Scientist Training Program at UC San Diego. He completed his doctoral thesis with Dr. Anirvan Ghosh, studying activity-dependent mechanisms regulating the assembly of hippocampal circuits in the developing brain. He went on to complete a residency in adult psychiatry and to do his postdoctoral research at UC San Francisco with Dr. Vikaas Sohal. The Wilke laboratory studies the prefrontal cortex, using molecular genetic tools to observe and alter activity in the brain during behavior. Ultimately his work seeks to understand the development and resolution of depressed states at the level of specific neural circuits. You can learn more about his research at www.wd2labs.org/wilke-lab.

Dr. Wilke is also an active clinician with expertise in interventional approaches to treat psychiatric conditions by modulating activity in the brain. He is an attending physician in the Neuromodulation Division of the Semel Institute for Neuroscience and Human Behavior and specializes in transcranial magnetic stimulation (TMS) to treat refractory depression.

Medical Board Certifications:

Psychiatry, American Board of Psychiatry and Neurology, 2016

Fellowship:

Research Fellowship, UCSF School of Medicine, 2016-2018

Residency:

Psychiatry, UCSF School of Medicine, 2012-2016

Degrees:

UCSD School of Medicine, MD, PhD, 2012

Walter Dunn, M.D., Ph.D.

Medical Board Certifications:

Psychiatry, American Board of Psychiatry and Neurology, 2014

Residency:

Psychiatry, UCLA Neuropsychiatric Hospital, 2011-2014

Internship:

Psychiatry, UCLA Neuropsychiatric Hospital, 2010-2011

Degree:

UC Davis, MD, 2010

UC Berkeley, PhD, 2005

Jason Jalil, M.D.

Medical Board Certifications:

Psychiatry, American Board of Psychiatry and Neurology, 2016

Fellowship:

Geriatric Psychiatry, UCLA School of Medicine, 2016-2017

Residency:

Psychiatry, UCLA School of Medicine, 2013-2016

Internship:

Psychiatry, UCLA School of Medicine, 2012-2013

Degree:

Sackler School of Medicine, MD, 2012

Staff

Name

Role

Michelle Abrams, RN Nurse
Nikita Vince-Cruz Research Manager
Jola Leskinen TMS Scheduling Coordinator
Kathy Garcia TMS Technician
Doan Ngo TMS Technician
Kristine Reina TMS Intake Coordinator